CX1739
CX1739 is a novel low-impact ampakine that can safely activate AMPA receptors without causing excito-neurotoxicity, rapidly crossing the blood-brain barrier, protecting against respiratory depression.
| Supplier | Ace Therapeutics |
|---|---|
| Product # | SMD464 |
| CAS # | unknown |
| Pricing | Customizable size, Inquiry |
| Synonym | CX1739; CX 1739; CX-1739; |
| Product Category | Lab-use Small Molecule Drugs |
| Chemical Formula | C13H15N3O3 |
| Exact Mass | 261.1113 |
| Molecular Weight | 261.281 |
| Elemental Analysis | C, 59.76; H, 5.79; N, 16.08; O, 18.37 |
| IUPAC/Chemical Name | N-methyl-N-(tetrahydro-2H-pyran-4-yl)benzo[c][1,2,5]oxadiazole-5-carboxamide |
| InChi Key | IRYRMRDDVXULFG-UHFFFAOYSA-N |
| InChi Code | InChI=1S/C13H15N3O3/c1-16(10-4-6-18-7-5-10)13(17)9-2-3-11-12(8-9)15-19-14-11/h2-3,8,10H,4-7H2,1H3 |
| SMILES Code | O=C(C1=CC2=NON=C2C=C1)N(C)C3CCOCC3 |
| Appearance | Solid powder |
| Purity | >98% (or refer to the Certificate of Analysis) |
| Shipping Condition | Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs. |
| Storage Condition | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| Solubility | Soluble in DMSO |
| Shelf Life | >2 years if stored properly |
| Drug Formulation | This drug may be formulated in DMSO |
| Stock Solution Storage | 0 - 4℃ for short term (days to weeks), or -20℃ for long term (months). |
| HS Tariff Code | 2934.99.9001 |